Free tool
FAERS Monitor: Augmentin '125'
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 050575 or its brand name (Augmentin '125', Amoxicillin, Clavulanate Potassium). Reports on generic versions are filed under their own applications.
Reports
27,162
Serious
21,127
78% of reports
Hospitalization
13,410
Death reported
2,624
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- diarrhoea1,873
- drug hypersensitivity1,824
- nausea1,449
- dyspnoea1,421
- pyrexia1,395
- fatigue1,292
- pneumonia1,204
- vomiting1,173
- rash1,031
- pain991
- headache947
- acute kidney injury860
- drug ineffective858
- pruritus858
- asthenia845
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 563 |
| 2005 | 450 |
| 2006 | 205 |
| 2007 | 142 |
| 2008 | 140 |
| 2009 | 716 |
| 2010 | 673 |
| 2011 | 869 |
| 2012 | 927 |
| 2013 | 1,030 |
| 2014 | 1,246 |
| 2015 | 1,602 |
| 2016 | 2,143 |
| 2017 | 1,954 |
| 2018 | 2,378 |
| 2019 | 2,414 |
| 2020 | 2,029 |
| 2021 | 1,337 |
| 2022 | 1,405 |
| 2023 | 1,423 |
| 2024 | 1,386 |
| 2025 | 1,228 |
| 2026 | 898 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,026,997 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug hypersensitivitySignal | 1,824 | 7.4 | 7.0 | 10,013 |
| acute kidney injurySignal | 860 | 4.4 | 4.1 | 2,236 |
| pyrexiaSignal | 1,395 | 3.1 | 3.0 | 2,046 |
| pneumoniaSignal | 1,204 | 2.9 | 2.7 | 1,500 |
| diarrhoeaSignal | 1,873 | 2.3 | 2.2 | 1,337 |
| dyspnoea | 1,421 | 1.9 | 1.8 | 669 |
| vomiting | 1,173 | 1.9 | 1.8 | 539 |
| rash | 1,031 | 1.8 | 1.7 | 397 |
| asthenia | 845 | 1.7 | 1.6 | 270 |
| pruritus | 858 | 1.7 | 1.6 | 268 |
| nausea | 1,449 | 1.4 | 1.3 | 185 |
| fatigue | 1,292 | 1.3 | 1.2 | 85 |
| pain | 991 | 1.2 | 1.2 | 51 |
| headache | 947 | 1.2 | 1.1 | 24 |
| drug ineffective | 858 | 0.5 | 0.5 | 447 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.